アメリカでの Dabigatran訴訟

By , 2012年8月22日 9:54 PM

以前お伝えした新薬 Dabigatran (商品名:プラザキサ) は、年間 10億ドル規模の売上を誇る抗凝固薬ですが、アメリカで集団訴訟とのニュースです

Blood-thinner Pradaxa target of mass-claims suit

By Bobby Allyn, The Tennessean

Updated 2d 13h ago

NASHVILLE, Tenn. — After taking the blood-thinning drug Pradaxa for three weeks,Charles Jackson experienced intestinal bleeding. His doctor told him to get off the drug, which he began taking after suffering a stroke last September.

Months later, Jackson, 75, a retired truck driver from the rural railroad community of Hohenwald, saw a television advertisement imploring patients who had complications with Pradaxa to dial 1-800-BAD-DRUG to learn more about joining a lawsuit against the drug company.

Now Jackson is among hundreds of other patients around the country who are teaming against an anti-stroke drug whose sales eclipsed $1 billion last year. Joining the suit thrusts Jackson into the high-dollar stream of product liability lawsuits, a burgeoning world of mass claims in which specialty law firms cast a wide net for injured consumers who represent the pitfalls of marketing risky products. (続きは上記タイトルリンク先参照)

この薬剤には様々なメリットがある一方で、副作用の出血性合併症についても、色々耳にしています (・・・とはいえ、従来使用されてきたワルファリンにも出血性合併症はあります)。アメリカでは、この薬剤のメリットと副作用のバランスをどう取るのか、今後の展開に注目です。

Post to Twitter


Leave a Reply

Panorama Theme by Themocracy